NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a 10-report earnings history dating back to Feb 28, 2024. Its average absolute post-earnings move is ±5.98%, and 80.0% of those reactions were positive. Its largest post-earnings gain was +13.65% (Nov 06, 2024) and its largest decline was -3.87% (Aug 07, 2024). The next earnings report is predicted for 2026-08-06 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
10
Avg Abs. Movement
±5.98%
Positive %
80.0%
Negative %
20.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 07, 2026 | ☀ PRE | $32.00 | $35.04 | $34.85 | 169,434 | +12.4% | open_in_new |
| Feb 18, 2026 | ☀ PRE | $35.40 | $37.60 | $35.78 | 45,453 | +1.47% | open_in_new |
| Nov 05, 2025 | ☀ PRE | $36.37 | $40.55 | $38.11 | 60,257 | +4.21% | open_in_new |
| Aug 06, 2025 | ☀ PRE | $21.76 | $23.64 | $23.64 | 45,727 | +8.94% | open_in_new |
| May 08, 2025 | ☀ PRE | $19.68 | $20.64 | $19.27 | 38,617 | +2.28% | open_in_new |
| Feb 26, 2025 | ☀ PRE | $18.43 | $19.77 | $19.76 | 98,071 | +10.39% | open_in_new |
| Nov 06, 2024 | ☀ PRE | $19.43 | $22.21 | $21.77 | 102,884 | +13.65% | open_in_new |
| Aug 07, 2024 | ☀ PRE | $16.23 | $16.26 | $15.65 | 11,872 | -3.87% | open_in_new |
| May 09, 2024 | ☀ PRE | $21.75 | $22.07 | $21.82 | 6,097 | +0.14% | open_in_new |
| Feb 28, 2024 | ☀ PRE | $23.64 | $24.71 | $23.60 | 9,676 | -2.48% | open_in_new |
Earnings Count
10
Total earnings in dataset
Avg Abs. Movement
±5.98%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
6 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| S-8 | 20260605 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260604 | open_in_new SEC.gov |
| 8-K | 20260603 | open_in_new SEC.gov |
| 4 | 20260527 | open_in_new SEC.gov |
| 144 | 20260526 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260514 | open_in_new SEC.gov |
Frequently asked about NAMS earnings
When does NewAmsterdam Pharma Company N.V. Ordinary Shares report earnings next? expand_more
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)'s next earnings date is approximate for 2026-08-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does NAMS stock move after earnings? expand_more
Over 10 reports, NAMS has moved an average of ±5.98% the session after earnings, closing higher 80.0% of the time.
What was NAMS's biggest post-earnings move? expand_more
NAMS's largest post-earnings gain on record was +13.65% on Nov 06, 2024, and its largest decline was -3.87% on Aug 07, 2024.
Where can I find NewAmsterdam Pharma Company N.V. Ordinary Shares's SEC filings? expand_more
All of NewAmsterdam Pharma Company N.V. Ordinary Shares's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right